These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32931001)

  • 21. Current opinion on the regulation of small intestinal magnesium absorption.
    Chamniansawat S; Suksridechacin N; Thongon N
    World J Gastroenterol; 2023 Jan; 29(2):332-342. PubMed ID: 36687126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hypomagnesemia and hypocalcemia associated with chronic omeprazole use].
    Cuesta Miyares J; López Caleya JF; Martín Rodrigo L
    Semergen; 2020; 46(1):e1-e2. PubMed ID: 31785990
    [No Abstract]   [Full Text] [Related]  

  • 23. Suppression of contractile activity in the small intestine by indomethacin and omeprazole.
    Lichtenberger LM; Bhattarai D; Phan TM; Dial EJ; Uray K
    Am J Physiol Gastrointest Liver Physiol; 2015 May; 308(9):G785-93. PubMed ID: 25721304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omeprazole increased small intestinal mucosal injury in two of six disease-free cases evaluated by capsule endoscopy.
    Fujimori S; Takahashi Y; Tatsuguchi A; Sakamoto C
    Dig Endosc; 2014 Sep; 26(5):676-9. PubMed ID: 25383403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
    Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
    J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked increase in gastric acid secretory capacity after omeprazole treatment.
    Waldum HL; Arnestad JS; Brenna E; Eide I; Syversen U; Sandvik AK
    Gut; 1996 Nov; 39(5):649-53. PubMed ID: 9026477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated hypomagnesemia in a patient treated with capecitabine.
    Rajapakse S; Rodrigo C; Rajapakse AC
    J Oncol Pharm Pract; 2013 Sep; 19(3):254-6. PubMed ID: 22948887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consistent gastric pH-dependent effects of suppressors of gastric acid secretion on the antihypertensive responses to oral nitrite.
    Sanches-Lopes JM; Ferreira GC; Pinheiro LC; Kemp R; Tanus-Santos JE
    Biochem Pharmacol; 2020 Jul; 177():113940. PubMed ID: 32224135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers.
    Goldstein JL; Scheiman JM; Fort JG; Whellan DJ
    J Cardiovasc Pharmacol; 2016 Aug; 68(2):121-6. PubMed ID: 27002280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of omeprazole on gastric mucosal blood flow in the conscious rat.
    Mattsson H; Larsson H
    Scand J Gastroenterol; 1987 May; 22(4):491-8. PubMed ID: 3602930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of proton pump inhibitor-induced hypomagnesemia.
    Gommers LMM; Hoenderop JGJ; de Baaij JHF
    Acta Physiol (Oxf); 2022 Aug; 235(4):e13846. PubMed ID: 35652564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI-induced hypomagnesemia.
    Gommers LMM; Ederveen THA; van der Wijst J; Overmars-Bos C; Kortman GAM; Boekhorst J; Bindels RJM; de Baaij JHF; Hoenderop JGJ
    FASEB J; 2019 Oct; 33(10):11235-11246. PubMed ID: 31299175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
    Kinoshita M; Saito N; Tamaki H
    Eur J Pharmacol; 1997 Mar; 321(3):325-32. PubMed ID: 9085044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of long-term administration of antisecretary drugs on rat gastric histamine synthesis and acid secretion--compare with omeprazole and cimetidine].
    Morita R; Harasawa S; Miwa T; Matsumoto M
    Nihon Shokakibyo Gakkai Zasshi; 1992 Oct; 89(10):2551-8. PubMed ID: 1404968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice.
    Hess MW; de Baaij JH; Gommers LM; Hoenderop JG; Bindels RJ
    PLoS One; 2015; 10(9):e0138881. PubMed ID: 26397986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.
    Lameris AL; Hess MW; van Kruijsbergen I; Hoenderop JG; Bindels RJ
    Pflugers Arch; 2013 Nov; 465(11):1613-20. PubMed ID: 23756852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo.
    Larsson H; Mattson H; Sundell G; Carlsson E
    Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
    Satoh H; Amagase K; Takeuchi K
    J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.